These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 22886150)

  • 1. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.
    Salkovic-Petrisic M; Knezovic A; Hoyer S; Riederer P
    J Neural Transm (Vienna); 2013 Jan; 120(1):233-52. PubMed ID: 22886150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study.
    Salkovic-Petrisic M; Osmanovic-Barilar J; Brückner MK; Hoyer S; Arendt T; Riederer P
    J Neural Transm (Vienna); 2011 May; 118(5):765-72. PubMed ID: 21533606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer's disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance.
    Akhtar A; Dhaliwal J; Sah SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1991-2009. PubMed ID: 33774703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.
    Sorial ME; El Sayed NSED
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):581-593. PubMed ID: 28188358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
    Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
    Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).
    Chen Y; Liang Z; Blanchard J; Dai CL; Sun S; Lee MH; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
    Mol Neurobiol; 2013 Apr; 47(2):711-25. PubMed ID: 23150171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.
    Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.
    Yeo HG; Lee Y; Jeon CY; Jeong KJ; Jin YB; Kang P; Kim SU; Kim JS; Huh JW; Kim YH; Sim BW; Song BS; Park YH; Hong Y; Lee SR; Chang KT
    J Alzheimers Dis; 2015; 46(4):989-1005. PubMed ID: 25881906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin.
    Lee Y; Kim YH; Park SJ; Huh JW; Kim SH; Kim SU; Kim JS; Jeong KJ; Lee KM; Hong Y; Lee SR; Chang KT
    J Alzheimers Dis; 2014; 38(2):251-67. PubMed ID: 23948941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
    Tahirovic I; Sofic E; Sapcanin A; Gavrankapetanovic I; Bach-Rojecky L; Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P
    Neurochem Res; 2007 Oct; 32(10):1709-17. PubMed ID: 17605105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism.
    Grieb P
    Mol Neurobiol; 2016 Apr; 53(3):1741-1752. PubMed ID: 25744568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal stress promotes icv-STZ-induced sporadic Alzheimer's pathology through central insulin signaling change.
    Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M
    Life Sci; 2020 Jan; 241():117154. PubMed ID: 31857087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic Alzheimer model.
    Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M
    Life Sci; 2017 Nov; 188():172-185. PubMed ID: 28867578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.
    Tong M; Deochand C; Didsbury J; de la Monte SM
    J Alzheimers Dis; 2016; 51(1):123-38. PubMed ID: 26836193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan--a preliminary study.
    Sapcanin A; Sofic E; Tahirovic I; Salkovic-Petrisic M; Hoyer S; Riederer P
    Neurotox Res; 2008 Apr; 13(2):97-104. PubMed ID: 18515212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate protective effect of Kyotorphin against the late consequences of intracerebroventricular streptozotocin model of Alzheimer's disease.
    Angelova H; Pechlivanova D; Krumova E; Miteva-Staleva J; Kostadinova N; Dzhambazova E; Landzhov B
    Amino Acids; 2019 Nov; 51(10-12):1501-1513. PubMed ID: 31520285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
    Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
    Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
    Tahirovic I; Sofic E; Sapcanin A; Gavrankapetanovic I; Bach-Rojecky L; Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P
    J Neural Transm Suppl; 2007; (72):235-40. PubMed ID: 17982899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease.
    Correia SC; Santos RX; Santos MS; Casadesus G; Lamanna JC; Perry G; Smith MA; Moreira PI
    Curr Alzheimer Res; 2013 May; 10(4):406-19. PubMed ID: 23061885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.